The Vice Presidents team at Immunovant comprises leaders responsible for specialized functions crucial to the company's success in developing and marketing treatments for autoimmune diseases. They oversee quality control, biostatistics, financial planning, drug safety, regulatory affairs, SEC reporting, marketing, process development, investor relations, IT, and human resources, ensuring cohesive strategy execution and regulatory compliance across the organization.
Andy Deig
VP, Financial Planning
Ant Kidwell
VP, IT & Facilities
Chau Cheng
VP, Investor Relations
Chedvi Levin-Sister
Vice President Finance
Claudia Jacobs
VP, CMC Project Management, Op...
Jody Roth
VP, Global Regulatory Affairs
Lauren Schrier
VP, Marketing
Lesa Valentine
VP, Quality
Thomas Hardy
VP, Drug Safety & Pharmacovigi...
Yan Zheng
VP, Biostatistics & Programmin...
View all